Quelle est la capitalisation boursière pour Specialty Natural Products Public Company Limited (SNPS)

La capitalisation boursière pour Specialty Natural Products Public Company Limited (SNPS) est $57.09M

Revenus de Specialty Natural Products Public Company Limited (SNPS)

Q: Quel est le prix pour Specialty Natural Products Public Company Limited (SNPS)

Le prix pour Specialty Natural Products Public Company Limited (SNPS) est $0.1409675

Specialty Natural Products Public Company Limited manufactures and distributes herbal extracts, cosmetics, beverages, health supplements, and traditional medicines in Thailand and internationally. The company also offers extracts for nutraceuticals and cosmeceuticals for use in weight and immune control, blood pressure and sugar, antiaging, hair nourishment, whitening, wound healing, UV protection, rejuvenation for men, slimming, cosmetic mosturerizing, antibacterial, antioxidant, nutrition, and anti-inflammatory; natural additives, such as eucalyptus, ginger, jojoba, kaffir lime, lavender, lemon, lemongrass, lime, orange, peppermint, plai, turmeric, rice bran, and tea tree oil; and other additives, including amino cleansers, concentrate shampoo, SNP-alpha arbutin, Argirena, clear soap, cremaflow, emulbase, ICM, nonawax, polyol complex, solubilisant, standard EB, surfactant base1, sunsil tin50, tiospere 50BG, TOG, supersil E, and standard EB. In addition, it provides herbal active pharmaceuticals ingredients comprising senna extract liquid and andrographis extract powder; packing services for cosmetics, beverages, and dietary supplements; production and distribution of electricity; and product research and development services. The company was incorporated in 1999 and is headquartered in Chonburi, Thailand.

Année	Revenus	Changez
Pas assez de données pour les dates fournies.

Année

Revenus

Changez

Pas assez de données pour les dates fournies.

Entreprise	Revenus	Différence de revenus	Pays
Royalty Pharma plc RPRX.US	$2.54B	-	US
Swedish Orphan Biovitrum AB SOBI.ST	-	-	SE
Ipsen S.A. IPN.PA	-	-	FR
Corcept Therapeutics Incorporated CORT.US	$830.81M	-	US
Sino Biopharmaceutical Limited 1177.HK	$4.55B	-	HK

Entreprise

Revenus

Différence de revenus

Pays